Varaico: Literature-Extracted Genetic Variants

Gene:CYP1A2
Variant:p.F21L
Back to variants list

CYP1A2

NM_000761.5:p.F21L

Associated Papers

Natural Polymorphic Variants in the CYP450 Superfamily: A Review of Potential Structural Mechanisms and Functional Consequences.

Prost R et al.

International Journal of Molecular Sciences, 2025

APF2: an improved ensemble method for pharmacogenomic variant effect prediction.

Zhou Y et al.

The Pharmacogenomics Journal, 2024

38802404 (PubMed )
Supplement: 41397_2024_338_MOESM2_ESM.xlsx › Sheet1

Effect of donor GSTM3 rs7483 genetic variant on tacrolimus elimination in the early period after liver transplantation.

Zhang T et al.

Peerj, 2024

39465171 (PubMed )
Supplement: peerj-12-18360-s002.7z › drug-metabolizing_enzymes_and_transporter__DMET__microarray › markerlist.xlsx › markerlist.TXT

Human Cytochrome P450 1, 2, 3 Families as Pharmacogenes with Emphases on Their Antimalarial and Antituberculosis Drugs and Prevalent African Alleles.

Chamboko CR et al.

International Journal of Molecular Sciences, 2023

36834793 (PubMed )
Supplement: ijms-24-03383-s001.zip › ijms-2130595-supplementary.pdf

Frequency of Important CYP450 Enzyme Gene Polymorphisms in the Iranian Population in Comparison with Other Major Populations: A Comprehensive Review of the Human Data.

Neyshaburinezhad N et al.

Journal of Personalized Medicine, 2021

34442448 (PubMed )
Supplement: jpm-11-00804-s001.zip › jpm-1270394-supplementary.pdf

In silico screening and analysis of nonsynonymous SNPs in human CYP1A2 to assess possible associations with pathogenicity and cancer susceptibility.

Navapour L et al.

Scientific Reports, 2021

Impact of peripheral mutations on the access channels of human cytochrome P450 1A2.

Ying B et al.

Journal of Biomolecular Structure & Dynamics, 2020

An optimized prediction framework to assess the functional impact of pharmacogenetic variants.

Zhou Y et al.

The Pharmacogenomics Journal, 2019

30206299 (PubMed )
Supplement: 41397_2018_44_MOESM5_ESM.xlsx › Sheet1

Functional characterization of 20 allelic variants of CYP1A2.

Ito M et al.

Drug Metabolism and Pharmacokinetics, 2015

Cytochrome P450 pharmacogenetics in African populations.

Alessandrini M et al.

Drug Metabolism Reviews, 2013

Genetic analysis of primaquine tolerance in a patient with relapsing vivax malaria.

Bright AT et al.

Emerging Infectious Diseases, 2013

23648098 (PubMed )
Supplement: 12-1852-Techapp-s1.pdf

Polymorphism of xenobiotic-metabolizing genes and breast cancer susceptibility in North Indian women.

Singh V et al.

Genetic Testing and Molecular Biomarkers, 2011

Functional characterization of eight human cytochrome P450 1A2 gene variants by recombinant protein expression.

Palma BB et al.

The Pharmacogenomics Journal, 2010

Structure, function, regulation and polymorphism and the clinical significance of human cytochrome P450 1A2.

Zhou SF et al.

Drug Metabolism Reviews, 2010

Insights into the substrate specificity, inhibitors, regulation, and polymorphisms and the clinical impact of human cytochrome P450 1A2.

Zhou SF et al.

The Aaps Journal, 2009

Genetic polymorphism and variability of chemical carcinogenesis.

Belitsky GA et al.

Biochemistry. Biokhimiia, 2008

CYP1A2 F21L and F186L polymorphisms in an Italian population sample.

Pucci L et al.

Drug Metabolism and Pharmacokinetics, 2007

Gene-environment interaction: the role of SULT1A1 and CYP3A5 polymorphisms as risk modifiers for squamous cell carcinoma of the oesophagus.

Dandara C et al.

Carcinogenesis, 2006

Functional analysis of three CYP1A2 variants found in a Japanese population.

Saito Y et al.

Drug Metabolism and Disposition: the Biological Fate of Chemicals, 2005

The G-113A polymorphism in CYP1A2 affects the caffeine metabolic ratio in a Chinese population.

Chen X et al.

Clinical Pharmacology and Therapeutics, 2005

Six novel nonsynonymous CYP1A2 gene polymorphisms: catalytic activities of the naturally occurring variant enzymes.

Murayama N et al.

The Journal of Pharmacology and Experimental Therapeutics, 2004

Frequency of -163 C>A and 63 C>G single nucleotide polymorphism of cytochrome P450 1A2 in two African populations.

Dandara C et al.

Clinical Chemistry and Laboratory Medicine, 2004

Genetic polymorphism of human cytochrome p450 involved in drug metabolism.

Nagata K et al.

Drug Metabolism and Pharmacokinetics, 2002

Identification of novel polymorphisms in the 5' flanking region of CYP1A2, characterization of interethnic variability, and investigation of their functional significance.

Aitchison KJ et al.

Pharmacogenetics, 2000

Detection of a novel cytochrome P-450 1A2 polymorphism (F21L) in Chinese.

Huang JD et al.

Drug Metabolism and Disposition: the Biological Fate of Chemicals, 1999

CYP1A2 polymorphism (C > A at position -163) in Ovambos, Koreans and Mongolians.

Fujihara J et al.

Cell Biochemistry and Function, 0

Select a paper to view details
UCSC Genome Browser·Imprint·Privacy·Terms·Feedback·Email Updates·

Regarding the variants extracted from papers and shown text snippets from research papers, the following holds: "Some rights reserved. This work permits non-commercial use, distribution and reproduction in any medium, provided the original author and source are credited."